ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro
diagnostics company, is pleased to announce that Suresh Vazirani,
Chairman of ERBA Diagnostics, will be a key note speaker at the
International Marketing Brief (IMB) in conjunction with the AACC. Over
800 of the owners and senior officers of worldwide diagnostic companies
and distributors are expected to attend the event.
ERBA Diagnostics Inc., USA will be exhibiting the full range of products
from ERBA international group of companies in USA, Italy, Czech
Republic, India and Turkey, including not only the Autoimmune and
Infectious Elisa product lines, but also the full line of biochemistry,
clinical chemistry and urine analysis products. About 10,000 potential
customers are expected to visit the Expo from all regions of the world.
ERBA will also be exhibiting for the first time in USA its new prototype
of its state-of-the-art microtiter and IFA processor LISA XL.
Most recently, IVAX Diagnostics, Inc. (NYSE MKT: IVD) has become ERBA
Diagnostics (NYSE MKT: ERB). With this corporate name and ticker symbol
change, ERBA Diagnostics signals its serious intention to develop brand
recognition and collaboration through the worldwide network of companies
affiliated with its majority stockholder - ERBA Diagnostics Mannheim